Insider NameBuy/SellCompany NameTickerAmountShares Change
Mar 08, 2024Mar 13, 2024Brumm Joshua T
CEO
Pres
SellDyne Therapeutics, Inc.DYN$25.89$11M-44.41%
Mar 07, 2024Mar 12, 2024Brumm Joshua T
CEO
Pres
SellDyne Therapeutics, Inc.DYN$25.85$234,873-1.61%
Feb 29, 2024Mar 02, 2024Brumm Joshua T
CEO
Pres
SellDyne Therapeutics, Inc.DYN$28.96$3M-15.07%
Jan 03, 2024Jan 05, 2024Brumm Joshua T
CEO
Pres
SellDyne Therapeutics, Inc.DYN$18.66$5M-31.56%
Dec 11, 2023Dec 12, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$10.72$81,311-1.28%
Sep 18, 2023Sep 20, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$9.41$113,221-4.90%
Sep 12, 2023Sep 13, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$10.41$79,866-3.03%
Jun 08, 2023Jun 13, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$12.9$4M-56.22%
Mar 14, 2023Mar 15, 2023Brumm Joshua TSellDyne Therapeutics, Inc.DYN$13.33$97,549-2.22%
Dec 12, 2022Dec 13, 2022Brumm Joshua TSellDyne Therapeutics, Inc.DYN$10.87$36,110-1.00%
Oct 07, 2022Oct 11, 2022Brumm Joshua TSellDyne Therapeutics, Inc.DYN$12.52$3M-52.62%
Mar 11, 2022Mar 14, 2022Brumm Joshua TSellDyne Therapeutics, Inc.DYN$8.73$29,542-1.58%
Sep 20, 2021Sep 23, 2021Brumm Joshua TSellDyne Therapeutics, Inc.DYN$15.9$127,312-7.48%
Oct 19, 2017Oct 23, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$2.55$3,381-0.65%
Jun 13, 2017Jun 14, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$16.05$22,807-1.33%
May 16, 2017May 17, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$17.4$21,976-1.17%
Feb 24, 2017Mar 01, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$20.94$628,063-22.09%
Jan 30, 2017Feb 01, 2017Brumm Joshua T
COO
CFO
SellVersartis, Inc.VSAR$13.85$40,794-2.71%
Dec 27, 2016Dec 29, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$15.85$15,692-1.50%
Dec 07, 2016Dec 08, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$13.25$40,028-4.39%
Jun 15, 2016Jun 17, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$10.63$15,392-2.40%
May 20, 2016May 20, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$7.87$9,956-2.06%
Dec 30, 2015Jan 04, 2016Brumm Joshua T
CFO
SellVersartis, Inc.VSAR$12.44$12,312-2.71%
Nov 12, 2015Nov 13, 2015Brumm Joshua T
CFO
BuyVersartis, Inc.VSAR$9.99$24,975+6.40%
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.